Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The KEAP1-NRF2 system and neurodegenerative diseases.
Uruno A, Yamamoto M. Uruno A, et al. Among authors: yamamoto m. Antioxid Redox Signal. 2023 Feb 3. doi: 10.1089/ars.2023.0005. Online ahead of print. Antioxid Redox Signal. 2023. PMID: 36734430
The KEAP1-NRF2 System and Neurodegenerative Diseases.
Uruno A, Yamamoto M. Uruno A, et al. Among authors: yamamoto m. Antioxid Redox Signal. 2023 May;38(13-15):974-988. doi: 10.1089/ars.2023.0234. Epub 2023 Mar 17. Antioxid Redox Signal. 2023. PMID: 36930785 Review.
A Point Mutation at C151 of Keap1 of Mice Abrogates NRF2 Signaling, Cytoprotection in Vitro, and Hepatoprotection in Vivo by Bardoxolone Methyl (CDDO-Me).
Gatbonton-Schwager T, Yagishita Y, Joshi T, Wakabayashi N, Srinivasan H, Suzuki T, Yamamoto M, Kensler TW. Gatbonton-Schwager T, et al. Among authors: yamamoto m. Mol Pharmacol. 2023 Aug;104(2):51-61. doi: 10.1124/molpharm.123.000671. Epub 2023 May 15. Mol Pharmacol. 2023. PMID: 37188495 Free PMC article.
Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway.
Kidokoro K, Kadoya H, Cherney DZI, Kondo M, Wada Y, Umeno R, Kishi S, Nagasu H, Nagai K, Suzuki T, Sasaki T, Yamamoto M, Kanwar YS, Kashihara N. Kidokoro K, et al. Among authors: yamamoto m. Kidney360. 2023 Oct 1;4(10):1454-1466. doi: 10.34067/KID.0000000000000171. Epub 2023 Jun 2. Kidney360. 2023. PMID: 37265366 Free PMC article.
Nrf2 activation improves experimental rheumatoid arthritis.
Zhang A, Suzuki T, Adachi S, Yoshida E, Sakaguchi S, Yamamoto M. Zhang A, et al. Among authors: yamamoto m. Free Radic Biol Med. 2023 Oct;207:279-295. doi: 10.1016/j.freeradbiomed.2023.07.016. Epub 2023 Jul 24. Free Radic Biol Med. 2023. PMID: 37494986 Free article.
jMorp: Japanese Multi-Omics Reference Panel update report 2023.
Tadaka S, Kawashima J, Hishinuma E, Saito S, Okamura Y, Otsuki A, Kojima K, Komaki S, Aoki Y, Kanno T, Saigusa D, Inoue J, Shirota M, Takayama J, Katsuoka F, Shimizu A, Tamiya G, Shimizu R, Hiratsuka M, Motoike IN, Koshiba S, Sasaki M, Yamamoto M, Kinoshita K. Tadaka S, et al. Among authors: yamamoto m. Nucleic Acids Res. 2024 Jan 5;52(D1):D622-D632. doi: 10.1093/nar/gkad978. Nucleic Acids Res. 2024. PMID: 37930845 Free PMC article.
Progress Report of the Tohoku Medical Megabank Community-based Cohort Study: Study Profile of the Repeated Center-based Survey During Second Period in Miyagi Prefecture.
Hozawa A, Nakaya K, Nakaya N, Nakamura T, Kogure M, Hatanaka R, Chiba I, Kanno I, Sugawara J, Kodama E, Hamanaka Y, Kobayashi T, Uruno A, Tsuchiya N, Hirata T, Narita A, Tsuboi A, Tamahara T, Otsuki A, Goto M, Taira M, Shimizu R, Suzuki K, Obara T, Kikuya M, Metoki H, Ishikuro M, Danjoh I, Ogishima S, Nagaie S, Minegishi N, Hiratsuka M, Kumada K, Nishijima I, Nobukuni T, Yamaguchi-Kabata Y, Nagami F, Kure S, Fuse N, Kinoshita K, Izumi Y, Kuriyama S, Yamamoto M. Hozawa A, et al. Among authors: yamamoto m. J Epidemiol. 2024 Sep 5;34(9):434-443. doi: 10.2188/jea.JE20230241. Epub 2024 Jul 31. J Epidemiol. 2024. PMID: 38403692 Free PMC article.
13,354 results
You have reached the last available page of results. Please see the User Guide for more information.